Raffi Asadorian

2019 - AcelRx Pharmaceuticals

In 2019, Raffi Asadorian earned a total compensation of $1M as Chief Financial Officer at AcelRx Pharmaceuticals, a 12% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$149,812
Option Awards$249,917
Salary$430,000
Stock Awards$172,563
Other$11,200
Total$1,013,492

Asadorian received $430K in salary, accounting for 42% of the total pay in 2019.

Asadorian also received $149.8K in non-equity incentive plan, $249.9K in option awards, $172.6K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Raffi Asadorian's compensation ranked 9,204th out of 13,971 executives tracked by ExecPay. In other words, Asadorian earned more than 34.1% of executives.

ClassificationRankingPercentile
All
9,204
out of 13,971
34th
Division
Manufacturing
3,689
out of 5,701
35th
Major group
Chemicals And Allied Products
1,400
out of 2,200
36th
Industry group
Drugs
1,193
out of 1,886
37th
Industry
Pharmaceutical Preparations
886
out of 1,398
37th

Pay ratio

Raffi Asadorian's Pay$1,013,492
Median Employee's Pay$206,159
Pay Ratio

5

to 1

In 2019, the annual total compensation of Raffi Asadorian was $1,013,492.

The annual total compensation of the median employee at AcelRx Pharmaceuticals was $206,159.

The ratio of Raffi Asadorian's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 24, 2020.

Asadorian's colleagues

We found four more compensation records of executives who worked with Raffi Asadorian at AcelRx Pharmaceuticals in 2019.

2019

Vincent Angotti

AcelRx Pharmaceuticals

Chief Executive Officer

2019

Pamela Palmer

AcelRx Pharmaceuticals

Chief Medical Officer

2019

Badri Dasu

AcelRx Pharmaceuticals

Chief Engineering Officer

2019

Lawrence Hamel

AcelRx Pharmaceuticals

Former Chief Development Officer

News

You may also like